WEU

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy

Dec 6 (Reuters) – Summit Therapeutics Inc (SMMT.O) said on Tuesday it would license China-based Akeso Inc’s (9926.HK) experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade. The deal involves an upfront payment of $500 million to Akeso, which will also be eligible for regulatory …

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy Read More »

Asia shares bank on eventual China opening; oil earnings

https://tmsnrt.rs/2zpUAr4 China shares push higher, dollar slips More Chinese cities ease coronavirus controls Cap on Russia oil comes into effect, impact uncertain SYDNEY, Dec 5 (Reuters) – Asian shares extended their rally on Monday as investors hoped steps to unwind pandemic restrictions in China would eventually brighten the outlook for global growth and commodity demand, …

Asia shares bank on eventual China opening; oil earnings Read More »

Bank of England’s Dhingra warns of deeper and longer recession with higher rates

LONDON, Dec 3 (Reuters) – Bank of England rate-setter Swati Dhingra said in an interview published on Saturday that higher interest rates could lead to a deeper and longer recession, adding there were few signs that demands for higher wages risked a wage- price spiral. While most of her colleagues backed a 75 basis-point hike …

Bank of England’s Dhingra warns of deeper and longer recession with higher rates Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

FDA pulls US authorization for Eli Lilly’s COVID drug bebtelovimab

Nov 30 (Reuters) – Eli Lilly and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron. Wednesday’s announcement takes away authorization from the last COVID-19 monoclonal antibody treatment, …

FDA pulls US authorization for Eli Lilly’s COVID drug bebtelovimab Read More »

WHO to use ‘mpox’ for monkeypox to tackle stigma

‘Monkeypox’ name to be phased out slowly WHO received more than 200 name proposals Some countries, individuals raised concerns GENEVA, Nov 28 (Reuters) – The World Health Organization said on Monday it would start using a new preferred term, “mpox”, as a synonym for monkeypox and urged others to follow suit after receiving complaints that …

WHO to use ‘mpox’ for monkeypox to tackle stigma Read More »

Rare success for Alzheimer’s research unlocks hope for future therapies

CHICAGO, Nov 29 (Reuters) – The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives . Drugmakers Eisai Co Ltd (4523.T) and Biogen (BIIB.O) reported in September that …

Rare success for Alzheimer’s research unlocks hope for future therapies Read More »

Asia shares, oil prices rally as China speculation swirls

https://tmsnrt.rs/2zpUAr4 China property shares rally on policy support Euro eyeing 5-mth high, dollar near 3-mth low on yen Oil prices rebound on China hopes, talk of output cuts SYDNEY, Nov 29 (Reuters) – Asian shares rallied on Tuesday as Beijing’s latest move to support developers boosted the property sector and rumors swirled that recent public …

Asia shares, oil prices rally as China speculation swirls Read More »